Lorcaserin Extended-Release Tablets and Nuwiq recombinant
Determining the interaction of Lorcaserin Extended-Release Tablets and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-NuZole
- Lorcaserin Extended-Release Tablets-Nuzyra
- Lorcaserin Extended-Release Tablets-Nuzyra (Omadacycline Injection)
- Lorcaserin Extended-Release Tablets-Nuzyra (Omadacycline Tablets)
- Lorcaserin Extended-Release Tablets-Nuzyra Intravenous
- Lorcaserin Extended-Release Tablets-Nuzyra oral/injection
- Nuwiq recombinant-Lorcaserin Hydrochloride
- Nuwiq recombinant-Lorcaserin Tablets
- Nuwiq recombinant-Lorcet
- Nuwiq recombinant-Lorcet Plus
- Nuwiq recombinant-Lorcet Tablets
- Nuwiq recombinant-Lorlatinib